Frits R Mooi Selected Research

pertactin

1/2020	Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site.
3/2011	Studies on Prn variation in the mouse model and comparison with epidemiological data.
2/2009	Immunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.
1/2008	Antibody responses to defined regions of the Bordetella pertussis virulence factor pertactin.
8/2007	The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition.
6/2002	Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frits R Mooi Research Topics

Disease

39	Whooping Cough (Pertussis) 12/2022 - 06/2002
13	Infections 01/2018 - 08/2005
4	With Papillary Renal Neoplasia Papillary Thyroid Carcinoma 01/2015 - 04/2003
3	Tetanus 07/2007 - 03/2007
3	Eosinophilia 07/2007 - 03/2007
3	Diphtheria 07/2007 - 03/2007
3	Immediate Hypersensitivity 07/2007 - 03/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2014
1	Communicable Diseases (Infectious Diseases) 11/2012
1	Poliomyelitis (Polio) 03/2007
1	Hypertrophy 03/2007
1	Hypersensitivity (Allergy) 03/2007
1	Coinfection 08/2005

Drug/Important Bio-Agent (IBA)

35	VaccinesIBA 12/2022 - 06/2002
8	Pertussis ToxinIBA 01/2014 - 06/2002
6	AntigensIBA 01/2020 - 05/2004
6	pertactin FDA Link 01/2020 - 06/2002
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2007
4	AntibodiesIBA 08/2014 - 04/2003
4	Immunoglobulin G (IgG)IBA 09/2012 - 03/2008
4	Virulence Factors (Pathogenicity Factors)IBA 03/2011 - 10/2007
3	Pertussis VaccineIBA 12/2011 - 03/2007
3	CytokinesIBA 02/2009 - 03/2007
3	Interleukin-5 (Interleukin 5)IBA 05/2008 - 03/2007
2	Hemagglutinins (Hemagglutinin)IBA 01/2020 - 06/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2015 - 01/2010
2	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014 - 06/2002
2	Acellular VaccinesIBA 02/2009 - 04/2003
2	Interleukin-17 (Interleukin 17)IBA 05/2008 - 03/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008 - 03/2007
2	Interleukin-4 (Interleukin 4)IBA 07/2007 - 03/2007
2	AluminumIBA 07/2007 - 03/2007
2	Immunoglobulin E (IgE)IBA 03/2007 - 03/2007
1	NLR ProteinsIBA 01/2017
1	Complement System Proteins (Complement)IBA 04/2015
1	NucleotidesIBA 03/2015
1	2-benzyl-3-iodo-propanoic acidIBA 08/2014
1	ImmunosorbentsIBA 09/2012
1	EnzymesIBA 09/2012
1	pertussis toxoidIBA 04/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2009
1	EpitopesIBA 02/2009
1	Interleukin-23 (Interleukin 23)IBA 05/2008
1	Toll-Like Receptor 4IBA 05/2008
1	Interferon-gamma (Interferon, gamma)IBA 03/2008
1	OligonucleotidesIBA 09/2007
1	LipopolysaccharidesIBA 07/2007
1	Interleukin-10 (Interleukin 10)IBA 03/2007
1	Interleukin-13IBA 03/2007
1	hydroxide ionIBA 03/2007
1	OvalbuminIBA 03/2007
1	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 03/2007

Therapy/Procedure

1	Therapeutics 01/2010